Evidence map›Paper›PMID 33788174›Full record

ArticleDrug safety2021

Correction to: Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.

Viviane Jusot, Frider Chimimba, Nettie Dzabala, Olga Menang, Joy Cole, Gregory Gardiner, Opokua Ofori-Anyinam, Olakunle Oladehin, Cecilia Sambakunsi, Mphatso Kawaye and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug safety, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Viviane JusotGSK, Wavre, Belgium. viviane.x.jusot@gsk.com.ORCID http://orcid.org/0000-0002-7747-8788
Frider ChimimbaCollege of Medicine, University of Malawi, Blantyre, Malawi.
Nettie DzabalaCollege of Medicine, University of Malawi, Blantyre, Malawi.ORCID http://orcid.org/0000-0003-3655-0736
Olga MenangPATH, Geneva, Switzerland.
Joy ColeGSK, London, UK.
Gregory GardinerGSK, London, UK.ORCID http://orcid.org/0000-0002-4379-2613
Opokua Ofori-AnyinamGSK, Wavre, Belgium.ORCID http://orcid.org/0000-0001-8099-6837
Olakunle OladehinGSK, Lagos, Nigeria.
Cecilia SambakunsiPharmacy Medicines and Poisons Board, Lilongwe, Malawi.
Mphatso KawayePharmacy Medicines and Poisons Board, Lilongwe, Malawi.
Jens-Ulrich StegmannGSK, Wavre, Belgium.ORCID http://orcid.org/0000-0002-3792-4368
Yolanda Guerra MendozaGSK, Wavre, Belgium.ORCID http://orcid.org/0000-0002-4001-7662

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33788174
PMCPMC8496567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.